Investors Encouraged to Participate in LifeMD Securities Fraud Lawsuit with Schall Law Firm

In a notable development for shareholders of LifeMD, Inc., a national shareholder rights litigation firm, Schall Law Firm, has announced its encouragement for investors who have suffered losses to participate in a forthcoming class action lawsuit. This legal action is centered around alleged violations of the Securities Exchange Act of 1934, specifically focusing on false and misleading statements issued by LifeMD concerning its business performance.

LifeMD, a provider of telehealth services, is currently facing scrutiny as it has been reported that the company made exaggerated claims about its market position and future performance. The allegations stem from statements published between May 7, 2025 and August 5, 2025, referred to as the ‘Class Period.’ During this time, LifeMD purportedly raised its fiscal guidance for 2025 without substantiating this outlook, overlooking critical factors such as customer acquisition costs associated with its weight loss drugs.

As the truth emerged regarding these misleading claims, investors began to experience significant financial repercussions. The firm's representatives are urging shareholders who bought LifeMD stocks and experienced a financial loss during this Class Period to connect with them before the deadline on October 27, 2025. Interested parties can reach out free of charge to discuss their options and potential participation in the lawsuit.

Brian Schall, an attorney at the Schall Law Firm, highlights the firm’s commitment to assist investors who have faced damages in the wake of such misleading corporate behavior.